EI
EyePoint, Inc
🇩🇪XFRA.PV3BGermanyHealthcare
€3.00EURdown -0.60 (-16.67%)OpenEnd of day9:27 AM
Price€3.00-0.60 (-16.67%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US30233G2093
- CUSIP
- Not reported
Company
- Employees
- 214
- Headquarters
- Watertown, United States
- Website
- https://eyepoint.bio
- CEO
- Dr. Jay S. Duker M.D.
Market
- Shares outstanding
- 82.8M
- Market cap
- €248.36M
Key dates
- Next earnings
- Nov 11, 2026
Highlights
- Market cap
- €248.36M
- EPS LTM
- -$3.54
- P/E LTM
- -4.13
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.79M-94.63%down year on year
- Net income
- -$306.64M-74.84%down year on year
- Gross margin
- 41.77%-56.1%down year on year
- Free cash flow
- -$271.28M-39.81%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.